Literature DB >> 6972418

Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

P M Schlievert, K N Shands, B B Dan, G P Schmid, R D Nishimura.   

Abstract

Toxic-shock syndrome (TSS) is believed to be caused by a toxin produced by Staphylococcus aureus. An exotoxin has been identified that is associated with strains of S. aureus isolated from patients with TSS. Coded strains of S. aureus were tested for the presence of the exotoxin by polyacrylamide gel isoelectric focusing. Sixty isolates of S. aureus were tested; 28 (100%) of 28 isolates from patients with TSS but only five (16%) of 32 control isolates produced the toxin (P much less than 0.001). This protein exotoxin, which was purified by differential precipitation with ethanol and thin-layer isoelectric focusing, had an isoelectric point of 7.2. When tested by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the toxin migrated as a homogeneous protein with a molecular weight of 22,000. The exotoxin produced fever in rabbits and enhanced susceptibility to lethal shock caused by endotoxin. Other biologic properties of the exotoxin included lymphocyte mitogenicity and the capacity to suppress synthesis of IgM antibody to sheep erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972418     DOI: 10.1093/infdis/143.4.509

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  224 in total

1.  Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals.

Authors:  P M Schlievert; L M Jablonski; M Roggiani; I Sadler; S Callantine; D T Mitchell; D H Ohlendorf; G A Bohach
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 2.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome.

Authors:  M Roggiani; J A Stoehr; S B Olmsted; Y V Matsuka; S Pillai; D H Ohlendorf; P M Schlievert
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

4.  Characterization of Staphylococcus aureus enterotoxin L.

Authors:  Paul M Orwin; J Ross Fitzgerald; Donald Y M Leung; Juan A Gutierrez; Gregory A Bohach; Patrick M Schlievert
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Residues 20, 22, and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2.

Authors:  T N Turner; C L Smith; G A Bohach
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

6.  Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein.

Authors:  M A Tomai; P M Schlievert; M Kotb
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

7.  A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Ningyan Wang; Daiva M Mattis; Eric J Sundberg; Patrick M Schlievert; David M Kranz
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

8.  Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.

Authors:  Dennis P Han
Journal:  Trans Am Ophthalmol Soc       Date:  2004

9.  Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

10.  Toxic shock syndrome in Utah--1976 to 1983.

Authors:  J A Jacobson; C R Nichols; E M Kasworm
Journal:  West J Med       Date:  1985-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.